Huida Gene: HuidaGene's gene-editing therapy named rare pediatric drug by FDA

Huida Gene: HuidaGene Doses First Patient in Gene Therapy Trial for Inherited Blindness

Huida Gene: HuidaGene Therapeutics: U.S. FDA AWARDS BOTH RARE PEDIATRIC DISEASE AND ORPHAN DRUG DESIGNATIONS TO HG204, A CRISPR RNA-EDITING THERAPY, FOR THE TREATMENT OF MECP2 DUPLICATION SYNDROME

Huida Gene: US FDA grants rare paediatric disease designation to HuidaGene's HG004 to treat inherited blindness

Huida Gene: Potential treatment for inherited blindness wins FDA fast-track

Huida Gene: HuidaGene Therapeutics Announces Publication of the World's First Guanine Base-Editor

Press Release: Huida Gene : HuidaGene Therapeutics' Novel DNA Gene-Editing System Cas12i Patent Granted by USPTO